However, in the study of non-small cell lung cancer cell lines A549 and H1299, isoflurane was shown to enhance cell proliferation in a dose-dependent manner via activation of the AKT-mTOR signaling pathway [14]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.